← The Wire
VKTXNasdaq
Viking Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1607678
Develops drug candidates for unmet medical needs through clinical trials
$3.34B
Market cap
$39.54
Last close
+3.9%
1D
+22.1%
5D
2.9M
Volume
Price · last 39 sessions+24.5%
May 4L $27.75 · H $39.54Jun 29
226
Total filings
May 26, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 26, 202610-Q10-QApr 30, 20268-KResults of OperationsApr 29, 2026DEFA14ADEFA14AApr 1, 2026DEF 14ADEF 14AApr 1, 202610-K10-KFeb 11, 20268-KResults of OperationsFeb 11, 202610-Q10-QOct 23, 20258-KResults of OperationsOct 22, 20258-KReg FD DisclosureAug 19, 202510-Q10-QJul 23, 20258-KResults of OperationsJul 23, 20258-KShareholder VoteMay 27, 202510-Q10-QApr 24, 2025DEFA14ADEFA14AApr 23, 20258-KResults of OperationsApr 23, 20258-KAuditor Change · Company UpdateApr 23, 2025DEFA14ADEFA14AApr 8, 2025DEF 14ADEF 14AApr 8, 20258-KMaterial Agreement · New Debt / ObligationMar 11, 202510-K10-KFeb 26, 20258-KResults of OperationsFeb 5, 20258-KReg FD DisclosureNov 4, 202410-Q10-QOct 23, 20248-KResults of OperationsOct 23, 202410-Q10-QJul 24, 20248-KResults of OperationsJul 24, 20248-KReg FD DisclosureJun 4, 20248-KExecutive Change · Shareholder VoteMay 23, 202410-Q10-QApr 25, 20248-KResults of OperationsApr 24, 2024DEFA14ADEFA14AApr 5, 2024DEF 14ADEF 14AApr 5, 20248-KReg FD DisclosureMar 26, 20248-KCompany UpdateMar 4, 2024424B5424B5Mar 1, 20248-KMaterial Agreement · Company UpdateMar 1, 2024424B5424B5Feb 27, 20248-KReg FD DisclosureFeb 27, 2024SC 13GSCHEDULE 13GFeb 13, 202410-K10-KFeb 7, 20248-KResults of OperationsFeb 7, 2024SC 13GSC 13GJan 26, 2024SC 13GSC 13GNov 2, 202310-Q10-QOct 25, 20238-KResults of OperationsOct 25, 202310-Q10-QJul 26, 20238-KResults of OperationsJul 26, 20238-KShareholder VoteJun 14, 20238-KBylaw AmendmentMay 11, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF 14AMay 1, 202310-Q10-QApr 26, 20238-KResults of OperationsApr 26, 2023SC 13GSC 13GApr 10, 20238-KCompany UpdateApr 3, 20238-KMaterial Agreement · Company UpdateMar 31, 2023424B5424B5Mar 31, 2023424B5424B5Mar 29, 20238-KReg FD DisclosureMar 28, 20238-KReg FD DisclosureMar 28, 202310-K10-KFeb 10, 20238-KResults of OperationsFeb 8, 2023SC 13GSC 13GJan 3, 202310-Q10-QOct 26, 20228-KResults of OperationsOct 26, 202210-Q10-QJul 27, 20228-KResults of OperationsJul 27, 2022SC 13GSC 13GJul 8, 20228-KShareholder VoteMay 26, 202210-Q10-QApr 27, 20228-KResults of OperationsApr 27, 2022DEFA14ADEFA14AApr 7, 2022DEF 14ADEF 14AApr 7, 202210-K10-KFeb 9, 20228-KResults of OperationsFeb 9, 202210-Q10-QNov 3, 20218-KResults of OperationsNov 3, 2021424B5424B5Aug 11, 20218-KMaterial Agreement · Agreement TerminatedJul 28, 2021
Insider Activity
In the 90 days to Mar 10, 2026: 1 insider bought $150K · 4 sold $12.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Aubuchon Neil WilliamChief Commercial Officer | Buy | 4,475 | $33.50 | $150K |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 132,454 | $32.29 | $4.3M |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 53,279 | $33.38 | $1.8M |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 41,276 | $34.22 | $1.4M |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 31,961 | $32.30 | $1.0M |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 31,961 | $32.29 | $1.0M |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 13,900 | $33.38 | $464K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 13,600 | $33.37 | $454K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 10,500 | $34.22 | $359K |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 10,300 | $34.24 | $353K |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 6,400 | $35.07 | $224K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 1,600 | $35.07 | $56K |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 1,500 | $32.09 | $48K |
| Jan 2, 2026 | Foehr Matthew WDirector | Sell | 16,000 | $35.11 | $562K |
| Oct 28, 2025 | Lian BrianPresident & CEO | Sell | 38,989 | $35.01 | $1.4M |
| Oct 28, 2025 | Mancini MariannaChief Operating Officer | Sell | 6,185 | $35.00 | $216K |
| Oct 28, 2025 | Zante GregChief Financial Officer | Sell | 6,185 | $35.00 | $216K |
| Oct 27, 2025 | Rowland Charles A JrDirector | Sell | 60,000 | $35.57 | $2.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance